CA2019745A1 - Preparation pour le traitement et la prevention des thromboses et des complications thromboemboliques, utilisation d'une telle preparation et methode de production - Google Patents

Preparation pour le traitement et la prevention des thromboses et des complications thromboemboliques, utilisation d'une telle preparation et methode de production

Info

Publication number
CA2019745A1
CA2019745A1 CA2019745A CA2019745A CA2019745A1 CA 2019745 A1 CA2019745 A1 CA 2019745A1 CA 2019745 A CA2019745 A CA 2019745A CA 2019745 A CA2019745 A CA 2019745A CA 2019745 A1 CA2019745 A1 CA 2019745A1
Authority
CA
Canada
Prior art keywords
preparation
treating
producing
same
thromboembolic complications
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
CA2019745A
Other languages
English (en)
Other versions
CA2019745C (fr
Inventor
Hans Peter Schwarz
Ewald Molinari
Yendra Linnau
Susanne Pfeiler
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Oesterreichisches Institut fuer Haemoderivate
Original Assignee
Immuno AG fuer Chemisch Medizinische Produkte
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Immuno AG fuer Chemisch Medizinische Produkte filed Critical Immuno AG fuer Chemisch Medizinische Produkte
Publication of CA2019745A1 publication Critical patent/CA2019745A1/fr
Application granted granted Critical
Publication of CA2019745C publication Critical patent/CA2019745C/fr
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14—Hydrolases (3)
    • C12N9/48—Hydrolases (3) acting on peptide bonds (3.4)
    • C12N9/50—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25)
    • C12N9/64—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue
    • C12N9/6421—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue from mammals
    • C12N9/6424—Serine endopeptidases (3.4.21)
    • C12N9/6464—Protein C (3.4.21.69)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/1703—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • A61K38/1709—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/43—Enzymes; Proenzymes; Derivatives thereof
    • A61K38/46—Hydrolases (3)
    • A61K38/48—Hydrolases (3) acting on peptide bonds (3.4)
    • A61K38/482—Serine endopeptidases (3.4.21)
    • A61K38/4866—Protein C (3.4.21.69)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/745—Blood coagulation or fibrinolysis factors
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/36—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans against blood coagulation factors
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
    • C07K16/40—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against enzymes
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Y—ENZYMES
    • C12Y304/00—Hydrolases acting on peptide bonds, i.e. peptidases (3.4)
    • C12Y304/21—Serine endopeptidases (3.4.21)
    • C12Y304/21069—Protein C activated (3.4.21.69)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/36—Blood coagulation or fibrinolysis factors

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Engineering & Computer Science (AREA)
  • Medicinal Chemistry (AREA)
  • Biochemistry (AREA)
  • Zoology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Wood Science & Technology (AREA)
  • Biophysics (AREA)
  • Immunology (AREA)
  • Hematology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biomedical Technology (AREA)
  • General Engineering & Computer Science (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Toxicology (AREA)
  • Biotechnology (AREA)
  • Microbiology (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Diabetes (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Marine Sciences & Fisheries (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
CA002019745A 1989-06-26 1990-06-25 Preparation pour le traitement et la prevention des thromboses et des complications thromboemboliques, utilisation d'une telle preparation et methode de production Expired - Fee Related CA2019745C (fr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
AT0155189A AT402153B (de) 1989-06-26 1989-06-26 Protein-s-hältige pharmazeutische präparation
ATA1551/89 1989-06-26

Publications (2)

Publication Number Publication Date
CA2019745A1 true CA2019745A1 (fr) 1990-12-26
CA2019745C CA2019745C (fr) 1996-12-31

Family

ID=3515833

Family Applications (1)

Application Number Title Priority Date Filing Date
CA002019745A Expired - Fee Related CA2019745C (fr) 1989-06-26 1990-06-25 Preparation pour le traitement et la prevention des thromboses et des complications thromboemboliques, utilisation d'une telle preparation et methode de production

Country Status (10)

Country Link
US (1) US5143901A (fr)
EP (1) EP0406216B1 (fr)
JP (1) JPH0338528A (fr)
AT (2) AT402153B (fr)
CA (1) CA2019745C (fr)
DE (1) DE59003060D1 (fr)
DK (1) DK0406216T3 (fr)
ES (1) ES2061007T3 (fr)
FI (1) FI94927C (fr)
NO (1) NO902823L (fr)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5256642A (en) * 1988-04-01 1993-10-26 The Johns Hopkins University Compositions of soluble complement receptor 1 (CR1) and a thrombolytic agent, and the methods of use thereof
US6458360B1 (en) 1990-04-25 2002-10-01 The Johns Hopkins University Soluble complement regulatory molecules
WO1993009807A1 (fr) * 1991-11-18 1993-05-27 The Scripps Research Institute Procedes d'inhibition de la thrombose par elevation des taux de proteine c activee endogene dans la circulation
CA2143125C (fr) * 1992-08-27 2008-09-23 Koenraad Mertens Anticorps specifiques pour une proteine hemostatique, leur utilisation pour l'isolement de la proteine intacte, les compositions hemostatiques depourvues de produits de degradation proeolytique de la proteine
DE4320294A1 (de) * 1993-06-18 1994-12-22 Immuno Ag Verwendung von humanem Protein C zur Verhinderung und Behandlung von Thrombozytenablagerungen
DE4418635C2 (de) * 1994-05-27 1997-07-24 Immuno Ag Pharmazeutische Zusammensetzung zur Vorbeugung und Behandlung von Blutgerinnungsstörungen
WO2001056532A2 (fr) * 2000-02-04 2001-08-09 The Scripps Research Institute Utilisations a des fins neuroprotectrices, antithrombotiques et anti-inflammatoires de la proteine c activee
KR20230030644A (ko) * 2020-06-29 2023-03-06 인쎄름 (엥스띠뛰 나씨오날 드 라 쌍떼 에 드 라 흐쉐르슈 메디깔) 항-단백질 단일-도메인 항체 및 이를 포함하는 폴리펩타이드

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5258288A (en) * 1986-07-25 1993-11-02 Genzyme Corporation Vector containing DNA encoding mature human protein S
CA1339946C (fr) * 1987-03-31 1998-07-07 Michael J. Griffith Methode d'ultrapurification pour les polypeptides
WO1989002747A1 (fr) * 1987-10-05 1989-04-06 The American National Red Cross Composition thrombolytique therapeutique

Also Published As

Publication number Publication date
ES2061007T3 (es) 1994-12-01
NO902823L (no) 1990-12-27
AT402153B (de) 1997-02-25
DK0406216T3 (da) 1994-01-17
ATA155189A (de) 1996-07-15
FI94927B (fi) 1995-08-15
CA2019745C (fr) 1996-12-31
ATE95818T1 (de) 1993-10-15
FI94927C (fi) 1995-11-27
EP0406216A2 (fr) 1991-01-02
DE59003060D1 (de) 1993-11-18
FI903197A0 (fi) 1990-06-26
EP0406216A3 (en) 1991-02-06
JPH0338528A (ja) 1991-02-19
US5143901A (en) 1992-09-01
EP0406216B1 (fr) 1993-10-13
NO902823D0 (no) 1990-06-25

Similar Documents

Publication Publication Date Title
CA2001572A1 (fr) Composes pour le traitement des symptomes de sevrage du tabac
GB8916849D0 (en) Compositions and process for the treatment of textiles
DE3991343D2 (en) Deformationsgeschoss, damit ausgeruestete munition, sowie verfahren zur herstellung des geschosses
AU1645995A (en) Leather treatment process for leather coloring, leather coloring process performed on leather thereby treated, and leather article produced by the leather coloring process
EP0198092A4 (fr) Magnesium ou alliage de magnesium a surface traitee, et procede de traitement de leur surface.
CA2000792A1 (fr) Methode de modification des proprietes d'un corps composite de matrice metallique
GB2225787B (en) Compositions and process for the treatment of textiles
EP0439545A4 (en) Methods of and compositions for diagnosing, monitoring and treating the early stages of osteosarthritis
CA2215923A1 (fr) Methode de traitement de la manie et du trouble bipolaire
CA2019745A1 (fr) Preparation pour le traitement et la prevention des thromboses et des complications thromboemboliques, utilisation d'une telle preparation et methode de production
AU3369589A (en) Asbestos-treating agent and process for treating asbestos
EP0333243A3 (fr) Antigène K5 sulfaté et ses fragments
CA2058948A1 (fr) Methodes de recuperation de chymosine produite par voie naturelle
CA2144728A1 (fr) Methode de traitement symptomatique du syndrome premenstruel avec de la vitamine d ou de la vitamine d et du calcium
KR970000398B1 (en) Process for the preparation of 1,1,1,2-tetrafluoro-2-chloroethan and pentafluorethane
ZA925892B (en) Organic nitrates, processes for their preparation and their use in the treatment of cardiovascular diseases.
EG18005A (en) Composition of the activation of fermentative processes and process for the acceleration of the fermentative degradation of natural products
GB2271509B (en) Antivenom immunesera
DE59003390D1 (de) Verfahren zur Herstellung von Butandiol-1,4 und Tetrahydrofuran.
AU2982689A (en) Heat treated chemically vapor deposited products and treatment method
EP0970962A3 (fr) Procédé pour préparer 2,2-difluorocetene silyl, 0,S-acetales et O,S-esters de l'acide alpha,alpha-difluoro-beta-silyloxy-1, 3-dioxolane-4-propanoique
CA2045546A1 (fr) Traitement de la dysfonction pulmonaire et de la dependance a l'egard du respirateur au moyen d'hormones de croissance
GB2217316B (en) Process for preserving waste,subsoils and the like
ZA912363B (en) Benzoxazine derivatives,process for their preparation and their use for the treatment or for the prophylaxis of deseases
EP0634380A3 (fr) Composition liquide pour le traitement des végétaux et procédé de fabrication d'une telle composition.

Legal Events

Date Code Title Description
EEER Examination request
MKLA Lapsed